Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
J., KANTER
4674  Ergebnisse:
Personensuche X
?
1

The clinical spectrum of HbSC sickle cell disease‐not a ben..:

Nelson, M. ; Noisette, L. ; Pugh, N....
British Journal of Haematology.  205 (2024)  2 - p. 653-663 , 2024
Link: https://doi.org/10.1111/..
 
?
2

5613436 EXPERT CONSENSUS ON THE MANAGEMENT OF INFUSION-RELA..:

Kanter, J. ; Ataga, K. ; Bhasin, N....
HemaSphere.  7 (2023)  S1 - p. 10-10 , 2023
Link: https://doi.org/10.1097/..
 
?
3

Outcomes of circumferential minimally-invasive technique vs..:

Tretiakov, P. ; Passias, P. ; Uribe, J....
Brain and Spine.  3 (2023)  - p. 102413 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Hormonal stimulation reduces numbers and impairs function o..:

Kanter, J ; Gordon, S M ; Mani, S...
Human Reproduction.  38 (2023)  6 - p. 1047-1059 , 2023
Link: https://doi.org/10.1093/..
 
?
5

What drives pediatric Burkitt lymphoma? Timing events in th..:

Steemers, A. ; de Kanter, J. ; Groenen, N....
Hematological Oncology.  41 (2023)  S2 - p. 603-604 , 2023
Link: https://doi.org/10.1002/..
 
?
6

S115: LONG-TERM EFFICACY AND SAFETY OF DEFERIPRONE FOR PATI..:

Inusa, B ; Hamdy, M ; El-Beshlawy, A...
HemaSphere.  6 (2022)  - p. 8-8 , 2022
Link: https://doi.org/10.1097/..
 
?
7

P1316: ASSESSING GENOMIC SAFETY OF ANTIVIRAL NUCLEOSIDE ANA..:

Peci, F. ; de Kanter, J. ; Groenen, N....
HemaSphere.  6 (2022)  - p. 1201-1202 , 2022
Link: https://doi.org/10.1097/..
 
?
8

PI-01: GRNDAD AND COUSIN: INVESTIGATOR-INITIATED COLLABORAT..:

J., LITTLE ; D., MANWANI ; J., KANTER...
HemaSphere.  6 (2022)  - p. 09-09 , 2022
Link: https://doi.org/10.1097/..
 
?
9

S122: SAFETY AND EFFICACY OF CRIZANLIZUMAB IN ADOLESCENTS W..:

Heeney, M ; Rees, D ; de Montalembert, M...
HemaSphere.  6 (2022)  - p. 12-12 , 2022
Link: https://doi.org/10.1097/..
 
?
10

S108: A SYSTEMATIC POST-MARKETING (PM) REVIEW OF RARE INFUS..:

Kanter, J ; Shah, A ; Joshi, V...
HemaSphere.  6 (2022)  - p. 4-5 , 2022
Link: https://doi.org/10.1097/..
 
?
11

P1472: INTERIM RESULTS OF SAFETY, TOLERABILITY, PHARMACOKIN..:

Bruno, P. ; Kanter, J. ; Ziegler, J....
HemaSphere.  6 (2022)  - p. 1354-1355 , 2022
Link: https://doi.org/10.1097/..
 
?
12

RANDOMIZED CONTROLLED TRIAL OF THE EFFICACY AND SAFETY OF D..:

Hamdy, M ; El-Beshlawy, A ; Ebeid, FS...
Hematology, Transfusion and Cell Therapy.  44 (2022)  - p. S338-S339 , 2022
Link: https://doi.org/10.1016/..
 
?
13

Examining the Relationship Between Novel Data from Electron..:

Palekar, R. ; Schill, T. ; Aldin, G....
International Journal of Infectious Diseases.  116 (2022)  - p. S101 , 2022
Link: https://doi.org/10.1016/..
 
?
14

S120: RANDOMIZED CONTROLLED TRIAL OF THE EFFICACY AND SAFET..:

Inusa, B ; Hamdy, M ; El-Beshlawy, A...
HemaSphere.  6 (2022)  - p. 10-11 , 2022
Link: https://doi.org/10.1097/..
 
?
15

68: Improving timeliness of CF diagnosis following a positi..:

Rosenfeld, M. ; Ong, T. ; Carlin, K....
Journal of Cystic Fibrosis.  20 (2021)  - p. S34 , 2021
Link: https://doi.org/10.1016/..
 
1-15